RESEARCH + DEVELOPMENT
Helping to account for ABG Lab’s success has been its strong research partnerships with world-renowned universities.
With a clear commitment to regenerative medicine, we lead the charge for cutting-edge aesthetic platforms for skin revitalization. This pioneering effort seeks to radically change how doctors can choose to treat the symptoms of aging skin, skin damage, and more, no longer limiting them to merely providing quick fixes. Instead, our partners and clinicians can focus on healing from the inside out by altering gene expression, stimulating adult stem cell activity, and restoring the skin at the cellular level—improving the skin’s natural homeostasis and overall performance.
The Eli and Edythe Broad Center Regeneration Medicine and Stem Cell Research
University of California - San Francisco, California
Early on, ABG Lab and the University of California, San Francisco, collaborated on research to map the full benefits of Wharton’s Jelly Peptide on mature skin stem cells. ABG Lab and UCSF continue to study the effects of our range of aesthetic solutions to further skincare science into the next generation.
Together with the University of California at San Francisco, ABG Lab initiated cutting-edge stem cell research on Meso-Wharton P199 led by renowned researchers and professors of Dermatology. The team at UCSF precisely mapped the benefits of Wharton’s Jelly Peptide on mature skin stem cells while charting the full profile of Wharton's Jelly Peptide and its regenerating potential. And in so doing, understanding the full scope of Wharton's Jelly Peptide's cellular benefits for aging skin.
Embry-Riddle Aeronautical University
Daytona Beach, Florida
ABG Lab is in partnership with Embry-Riddle Aeronautical University for additional research into protecting astronauts' skin by leveraging the science of fluid dynamics and 3-Dimensional Computer Modeling to determine the precise application and efficacy of mesotherapy treatments to fulfill this purpose.
Embry-Riddle Aeronautical University has been enlisted to conduct groundbreaking research using 3D-modeling applications of the epidermis that will revolutionize the understanding of ABG Lab's mesotherapy technologies in the skin and their pharmacological effects.
Leveraging the profound science of fluid dynamics, Professors of Aeronautical Engineering at ERAU and their highly-skilled team of scientists are using high-fidelity numerical studies of transdermal dynamics on selected ABG Lab peptide-based compounds; while developing conclusive evidence for assisting ABG Lab in the research and development of effective and safe future skincare technologies.
ABG Lab has created an array of technologies that aim to do one thing — regenerate aging skin by altering gene expression, stimulating adult stem cell activity, and repairing the skin at the cellular level, improving natural skin homeostasis and cellular performance.
Since its founding by Dr. Elina Tester, a molecular biochemist, ABG Lab has pioneered advanced mesotherapy platforms. ABG Lab produces innovative & comprehensive anti-aging solutions, meeting the demand for aesthetic and topical skin rejuvenation solutions required by medical professionals, cosmeticians, and skincare markets worldwide.
We spearhead the development of an array of cutting-edge aesthetic solutions that have revolutionized how doctors can choose to treat the signs of premature aging skin showing signs of damage, and much more.
Solutions that empower individuals by addressing the underlying causes of skin aging, providing a comprehensive solution that goes beyond superficial results.
Research affiliates from a variety of scientific backgrounds and medical fields have represented ABG Lab throughout the years, including:
Dr. Boris Petrikovsky, MD, Ph.D.
Mount Sinai Hospital New York, NY
Dr. Michael Kane, MD
Kane Plastic Surgery New York, NY
Dr. Ruby Ghadially, MD
University of California San Francisco San Francisco, CA
Dr. Vladimir Golubev, Ph.D.
Embry-Riddle Aeronautical University Daytona, FL